(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN enhancer)))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NN NFAT-1))))) (. .))
(S (NP-SBJ-33 (NP (DT The) (NN function)) (PP (IN of) (NP (DT a) (JJ putative) (NN NFAT-1) (NN site))) (PP (IN in) (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN enhancer)))) (VP (VBZ has) (VP (VBN been) (VP (VBN analyzed) (NP (-NONE- *-33))))) (. .))
(S (NP-SBJ-34 (NP (NN Activation)) (PP (IN by) (NP (DT the) (NN T-cell) (NN antigen) (NN receptor)))) (VP-COOD (VP (VBZ is) (ADJP-PRD (JJ minimal)) (PP (IN in) (NP (NN Jurkat) (NNS cells)))) (CC and) (VP (VBZ is) (VP (VBN mediated) (NP (-NONE- *-34)) (PP (IN by) (NP-LGS (DT the) (NN kappa) (NN B) (NNS sites)))))) (. .))
(S-COOD (S (NP-SBJ-35 (DT The) (JJ putative) (NN NFAT-1) (NN region)) (VP (VBZ is) (RB not) (VP (VBN required) (NP (-NONE- *-35)) (PP (IN for) (NP (NP (DT the) (NN response)) (PP-COOD (PP (TO to) (NP (NN anti-CD3))) (CC or) (PP (TO to) (NP (NNS mitogens)))) (PP (IN in) (NP (NP-COOD (NP (NN T-cell)) (, ,) (NP (NN B-cell)) (, ,) (CC or) (NP (NN (macrophage monocyte)) (NN leukemia))) (NNS lines)))))))) (, ,) (CC nor) (SINV (VP (VBZ is)) (NP-SBJ (PRP it)) (NP-PRD (DT a) (JJ cis-acting) (JJ negative) (JJ regulatory) (NN element))) (. .))
